Last refreshed: October 26, 2026 (US ET)
Back to holdings

A

Growth

AGILENT TECHNOLOGIES INC.

Health Care·Life Sciences Tools & ServicesYield: Low (<1%)

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.

Close · 3M

+32.53%

A · 3M

+32.53%

Pinch / wheel to zoom · drag to pan · double-tap to reset

Held by 1 AI ETF

AIEQ0.780%

as of Oct 26

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals24
Win rate96% (23/24)
Avg buy return+15.17%
AIEQnow 0.780% of fund9 signals

AIEQ · Weight increase · 2d

weight 0.760% → 0.790% (+0.030 pp)·stock up 5.2% in the 30 days before

Oct 22·entry $173.89·now $173.07Fresh

-0.47%
since Oct 22

AIEQ · Weight increase · 2d

weight 0.550% → 0.780% (+0.230 pp)·stock up 11.2% in the 30 days before

Oct 1·entry $166.68·now $173.07Drifting

+3.83%
since Oct 1

AIEQ · Accumulation · 5d

weight 0.470% → 0.530% (+0.060 pp)·stock up 7.7% in the 30 days before

Sep 23·entry $165.32·now $173.07Drifting

+4.69%
since Sep 23

AIEQ · Accumulation · 5d

weight 0.460% → 0.510% (+0.050 pp)·stock up 5.2% in the 30 days before

Sep 22·entry $167.26·now $173.07Drifting

+3.47%
since Sep 22

AIEQ · Weight increase · 4d

weight 0.460% → 0.500% (+0.040 pp)·stock up 0.7% in the 30 days before

Sep 18·entry $156.47·now $173.07Chased

+10.61%
since Sep 18

AIEQ · Weight increase · 3d

weight 0.460% → 0.490% (+0.030 pp)·stock up 5.3% in the 30 days before

Sep 17·entry $156.34·now $173.07Chased

+10.70%
since Sep 17

AIEQ · Weight increase · 2d

weight 0.460% → 0.480% (+0.020 pp)·stock up 3.5% in the 30 days before

Sep 16·entry $153.69·now $173.07Chased

+12.61%
since Sep 16

AIEQ · Weight decrease · 2d

weight 0.480% → 0.460% (-0.020 pp)·stock up 6.7% in the 30 days before

Sep 4·entry $150.86·now $173.07

+14.72%
since Sep 4

AIEQ · New entry · 1d

stock down 1.9% in the 30 days before

Jul 1·entry $133.39·now $173.07Chased

+29.75%
since Jul 1
AIVLno longer held21 signals

AIVL · Exit · 1d

weight 0.824% → 0 (exited)·stock up 8.8% in the 30 days before

Sep 2·entry $151.39·now $173.07

+14.32%
since Sep 2

AIVL · Accumulation · 5d

weight 0.789% → 0.840% (+0.051 pp)·stock up 12.4% in the 30 days before

Aug 27·entry $157.69·now $173.07Drifting

+9.75%
since Aug 27

AIVL · Accumulation · 5d

weight 0.787% → 0.822% (+0.035 pp)·stock up 10.3% in the 30 days before

Aug 26·entry $155.08·now $173.07Chased

+11.60%
since Aug 26

AIVL · Accumulation · 6d

weight 0.780% → 0.826% (+0.045 pp)·stock up 12.2% in the 30 days before

Aug 25·entry $154.77·now $173.07Chased

+11.82%
since Aug 25

AIVL · Accumulation · 5d

weight 0.787% → 0.818% (+0.032 pp)·stock up 10.7% in the 30 days before

Aug 24·entry $153.43·now $173.07Chased

+12.80%
since Aug 24

AIVL · Accumulation · 5d

weight 0.787% → 0.849% (+0.062 pp)·stock up 13.8% in the 30 days before

Aug 21·entry $159.00·now $173.07Drifting

+8.85%
since Aug 21

AIVL · Weight increase · 4d

weight 0.780% → 0.835% (+0.055 pp)·stock up 17.1% in the 30 days before

Aug 20·entry $156.30·now $173.07Chased

+10.73%
since Aug 20

AIVL · Weight increase · 3d

weight 0.780% → 0.825% (+0.045 pp)·stock up 17.0% in the 30 days before

Aug 19·entry $155.41·now $173.07Chased

+11.36%
since Aug 19

AIVL · Weight increase · 2d

weight 0.780% → 0.789% (+0.009 pp)·stock up 14.0% in the 30 days before

Aug 18·entry $148.44·now $173.07Chased

+16.59%
since Aug 18

AIVL · Accumulation · 5d

weight 0.751% → 0.796% (+0.045 pp)·stock up 11.5% in the 30 days before

Aug 11·entry $149.49·now $173.07Chased

+15.77%
since Aug 11

AIVL · Weight increase · 3d

weight 0.749% → 0.790% (+0.041 pp)·stock up 10.7% in the 30 days before

Aug 10·entry $148.72·now $173.07Chased

+16.37%
since Aug 10

AIVL · Weight increase · 2d

weight 0.749% → 0.774% (+0.025 pp)·stock up 9.3% in the 30 days before

Aug 7·entry $145.97·now $173.07Chased

+18.57%
since Aug 7

AIVL · Weight increase · 3d

stock up 10.3% in the 30 days before

Jul 23·entry $139.74·now $173.07Chased

+23.85%
since Jul 23

AIVL · Weight increase · 2d

stock up 5.5% in the 30 days before

Jul 22·entry $133.46·now $173.07Chased

+29.68%
since Jul 22

AIVL · Weight decrease · 4d

stock up 4.8% in the 30 days before

Jul 20·entry $130.26·now $173.07

+32.87%
since Jul 20

AIVL · Weight decrease · 3d

stock up 2.4% in the 30 days before

Jul 17·entry $131.46·now $173.07

+31.65%
since Jul 17

AIVL · Weight decrease · 2d

stock up 4.2% in the 30 days before

Jul 16·entry $136.10·now $173.07

+27.16%
since Jul 16

AIVL · Weight increase · 2d

stock down 0.9% in the 30 days before

Jul 10·entry $134.29·now $173.07Chased

+28.88%
since Jul 10

AIVL · Weight decrease · 2d

stock down 4.9% in the 30 days before

Jul 6·entry $130.60·now $173.07

+32.52%
since Jul 6

AIVL · Accumulation · 5d

stock down 3.2% in the 30 days before

Jul 2·entry $130.69·now $173.07Chased

+32.43%
since Jul 2

AIVL · Accumulation · 5d

stock down 1.9% in the 30 days before

Jul 1·entry $133.39·now $173.07Chased

+29.75%
since Jul 1

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.

Buffett-style framework

Fails the frameworkas of Sep 6

AI ETF AIVL had recently accumulated shares but subsequently executed a full exit, while AIEQ also shows a trend of decreasing its weight in Agilent. This aligns with the framework's 'Fail' verdict, which primarily stems from the lack of a sufficient margin of safety at current prices.

  • Circle of CompetenceThe business of providing life science tools and services, including recurring consumables and maintenance, exhibits sufficiently stable unit economics to reasonably project cash flows over a decade.
  • Economic MoatAgilent benefits from significant customer switching costs due to integrated instrument platforms and specialized consumables, alongside a strong brand reputation for accuracy and reliability in scientific markets.
  • ManagementThe provided financial data does not offer sufficient information to assess management's candor, capital allocation discipline, or alignment of interests.
  • Financial HealthKey metrics like 10-year average ROE, operating margins, debt levels, and owner earnings are not provided, preventing a comprehensive assessment of financial health.
  • Margin of SafetyThe current valuation multiples, including a PER of 29.54 and EV/EBITDA of 35.3, suggest the market is pricing in significant future growth, leaving little to no margin of safety based on conservative intrinsic value estimates.

Agilent Technologies operates within a predictable circle of competence, underpinned by a durable economic moat from high switching costs and brand reputation. However, a comprehensive assessment of management and financial health is incomplete due to data limitations. Critically, the current market price does not offer a margin of safety, making it unattractive from a value-investing perspective, despite the underlying business quality.

Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.